Indica Labs Introduces HALO AI Apps for Enhanced Life Sciences Image Analysis
Indica Labs has launched a new suite of HALO AI Apps, expanding their AI capabilities for life sciences. These pre-trained tissue classifiers and cell phenotypers are designed for tissue-based research and offer out-of-the-box functionality across various tissue types. The release includes 11 new apps, with plans for further expansion.
These HALO AI Apps can be applied to specific regions of interest, fields of view, or entire whole slide images, offering flexibility in research settings. Researchers can use these apps directly or customize them with additional training based on their own images and data.
For instance, the NSCLC IHC Cancer Cell Phenotyper can be integrated with the HALO Multiplex IHC module to measure biomarker intensity specifically in cancer cells. Similarly, the Pan-Cancer H&E Lymphocyte Cell Phenotyper App can be used with the Spatial Analysis module to investigate immune infiltration and spatial relationships between lymphocytes and cancer cells within the tumor microenvironment.
Steven Hashagen, CEO at Indica Labs, commented:
“The new life science apps are a game changer for researchers who desire AI solutions that work out-of-the-box rather than building their own models,” ... “Each app is pretrained on hundreds of images and training annotations and is generalized across data from different scanners and institutions to deliver robust performance.”
Dr. Kate Lillard, Chief Scientific Officer at Indica Labs, emphasized the potential of these apps to accelerate research:
“HALO AI Apps will help scientists accelerate their research by reducing the amount of data and time required to train new models from scratch. Our Apps handle time-consuming and tedious tasks to provide consistent and standardized measurements, freeing customers to apply their scientific expertise where it’s needed most—in the interpretation of data to make informed decisions.”
The 11 new HALO AI Apps include:
• Breast IHC Cancer Cell Phenotyper
• Breast IHC Tumor Tissue Detection
• CRC H&E Cancer Cell Phenotyper
• Gastric H&E Tumor Tissue Detection
• HNSCC H&E Tumor Tissue Detection
• NSCLC H&E Cancer Cell Phenotyper
• NSCLC H&E Tumor Tissue Detection
• NSCLC IHC Cancer Cell Phenotyper
• NSCLC IHC Tumor Tissue Detection
• Ovarian H&E Tumor Tissue Detection
• Pan-Cancer H&E Lymphocyte Cell Phenotyper
The HALO AI Apps are now available for trial and purchase, requiring HALO and HALO AI 4.0.5 or later. A webinar introducing the new apps is scheduled for September 26. For clinical applications, Indica Labs offers HALO Clinical AI algorithms integrated into the HALO AP platform.
Image credit: ElementalImaging
Topics: Tools & Methods
